Annual Drug Patent Expirations for TRUSELTIQ
Truseltiq is a drug marketed by Qed Therap and is included in one NDA. There are three patents protecting this drug.
This drug has one hundred and sixteen patent family members in forty countries.
The generic ingredient in TRUSELTIQ is infigratinib phosphate. Additional details are available on the infigratinib phosphate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com